Henrik Krarup Selected Research

Henrik Krarup Research Topics

Disease

21	Infections 02/2022 - 09/2007
7	Chronic Hepatitis C 01/2019 - 01/2011
4	Adenocarcinoma 05/2021 - 01/2016
4	Hepatitis B 03/2017 - 06/2011
4	Inflammation (Inflammations) 01/2013 - 01/2009
4	Acute-Phase Reaction 01/2011 - 05/2003
4	HIV Infections (HIV Infection) 07/2009 - 05/2003
3	Fibrosis (Cirrhosis) 12/2018 - 06/2011
3	Disease Progression 01/2018 - 05/2015
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2017 - 10/2015
3	Liver Diseases (Liver Disease) 01/2017 - 05/2015
3	Pulmonary Tuberculosis 07/2009 - 04/2006
2	Necrosis 01/2024 - 07/2023
2	Persistent Infection 01/2023 - 02/2022
2	Liver Neoplasms (Liver Cancer) 11/2022 - 07/2010
2	Neoplasms (Cancer) 11/2022 - 12/2017
2	Chronic Pancreatitis 05/2021 - 01/2019
2	Chronic Hepatitis B 12/2018 - 01/2016
2	Diabetes Mellitus 12/2017 - 04/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2017 - 01/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2016 - 05/2015
2	Anemia 01/2016 - 09/2007
2	Pancreatic Diseases (Pancreatic Disease) 01/2016 - 10/2015
2	Tuberculosis (Tuberculoses) 05/2014 - 01/2013
2	Hookworm Infections (Hookworm Infection) 07/2009 - 09/2007
2	Malaria 05/2003 - 12/2002
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 10/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Exocrine Pancreatic Insufficiency 01/2019
1	Viremia 12/2018
1	Carcinogenesis 01/2016
1	Vitamin D Deficiency 11/2015
1	Insulin Resistance 11/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2015
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2013
1	Chronic Renal Insufficiency 01/2013
1	Atherosclerosis 01/2013
1	Substance-Related Disorders (Drug Abuse) 01/2013
1	Communicable Diseases (Infectious Diseases) 01/2013

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2024 - 05/2015
5	DNA (Deoxyribonucleic Acid)IBA 05/2021 - 10/2015
5	Cell-Free Nucleic AcidsIBA 05/2021 - 10/2015
4	Ribavirin (Virazole)FDA LinkGeneric 01/2018 - 01/2013
4	InterferonsIBA 01/2018 - 01/2013
4	Vitamin D FDA LinkGeneric 11/2016 - 12/2008
4	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2013 - 12/2002
4	Ferritins (Ferritin)IBA 07/2009 - 05/2003
4	IronIBA 07/2009 - 05/2003
4	alpha 1-Antichymotrypsin (alpha 1 Antichymotrypsin)IBA 01/2009 - 12/2002
3	hydroxide ionIBA 01/2022 - 12/2008
3	Antiviral Agents (Antivirals)IBA 12/2018 - 07/2010
3	Glucose (Dextrose)FDA LinkGeneric 04/2016 - 11/2010
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2024 - 07/2023
2	Proteins (Proteins, Gene)FDA Link 11/2022 - 05/2015
2	VaccinesIBA 02/2022 - 01/2022
2	AntigensIBA 01/2022 - 05/2014
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2019 - 01/2014
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2018 - 02/2017
2	HaptoglobinsIBA 12/2017 - 01/2013
2	NucleotidesIBA 01/2017 - 06/2011
2	Neutralizing AntibodiesIBA 10/2016 - 01/2013
2	LDL CholesterolIBA 11/2015 - 11/2010
2	C-Reactive ProteinIBA 01/2013 - 11/2010
2	Diethylcarbamazine (Hetrazan)FDA Link 01/2009 - 09/2007
2	Vitamin A (Retinol)FDA LinkGeneric 01/2009 - 05/2003
2	VitaminsIBA 01/2009 - 04/2006
2	beta Carotene (Betacarotene)FDA Link 01/2009 - 05/2003
1	Endothelin-1 (Endothelin 1)IBA 07/2023
1	EpitopesIBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2022
1	Long Noncoding RNAIBA 11/2022
1	AddavaxIBA 01/2022
1	AluminumIBA 01/2022
1	Broadly Neutralizing AntibodiesIBA 01/2019
1	Amylases FDA Link 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	TabletsIBA 12/2018
1	Terminator Codon (Termination Codon)IBA 01/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018
1	sofosbuvir drug combination ledipasvirIBA 01/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 03/2017
1	Immunoglobulins (Immunoglobulin)IBA 02/2017
1	SofosbuvirIBA 01/2017
1	nasIBA 01/2016
1	entecavir FDA Link 01/2016
1	Tenofovir (Viread)FDA Link 01/2016
1	25-hydroxyvitamin DIBA 11/2015
1	LipidsIBA 11/2015
1	CholesterolIBA 11/2015
1	Amino Acids FDA Link 08/2015
1	Interferon-gamma (Interferon, gamma)IBA 05/2014
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2014
1	Peptide Hydrolases (Proteases)FDA Link 01/2014
1	telaprevirIBA 01/2014
1	ORALIT (ORS)IBA 01/2013
1	Glycoproteins (Glycoprotein)IBA 01/2013

Therapy/Procedure

4	Therapeutics 12/2018 - 10/2011
4	Aftercare (After-Treatment) 06/2011 - 09/2007
1	Orthognathic Surgery 10/2023
1	Liver Transplantation 12/2017